92/5000 Preoperative Efficacy of Traumeel Versus Dexamethasone in the Control of Pain, Swelling and Trismus

NCT03567369 — Not applicable, Unknown, 17 participants, Federal University of the Valleys of Jequitinhonha and Mucuri

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Comparative Study of the Preoperative Efficacy of Traumeel Versus Dexamethasone in Control of Pain, Swelling and Trismus After Mandibular Third Molar Extractions

RegistryNCT03567369
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, crossover, masking: triple, treatment
Enrollment17 (Estimated)
SponsorFederal University of the Valleys of Jequitinhonha and Mucuri (Other)
ConditionsMolar, Third, Surgery
InterventionsDexamethasone, Traumeel S (Drug)
Datesstart 2018-04-02, primary completion 2018-07-31 (estimated), completion 2018-10-31 (estimated), first posted 2018-06-25, last updated 2018-06-25
Locations1 site in Brazil

Related Papers Related Patents Related Grants Related Experts
All trials for Molar, Third All trials for Surgery All trials of Dexamethasone All trials of Traumeel S

-Summary

To compare the efficacy of intramuscular injection of two anti-inflammatory drugs, Traumeel and Dexamethasone, used in the control of postoperative complications pain, edema and trismus after third molar extraction mandibular

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
DexamethasoneExperimentalDrug: DexamethasoneDexamethasone 4,0 mg / mL
Traumeel SExperimentalDrug: Traumeel STraumeel 2,2 mg / mL
  • Dexamethasone (Drug), also known as Dexamethasone Acetate, Decadron®: Dexamethasone 4,0 mg/mL
  • Traumeel S (Drug): Traummel S 2,2 mg/mL

+Outcome measures

Primary outcomes

  • Postoperative sequelae following thir molar extraction [up to seven days postoperative]: During the postoperative intervals of 24, 48 and 72 hours and seven days, the swelling was determined using linear measures in the face and trismus by maximum mouth opening. The postoperative pain was self-recorded by the patient using visual analogue scale in 72 hours with an interval of eight hours

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Patients with indication of asymptomatic bilateral extractions of lower third molars;
* Aged 18 years or older;
* Have a good health and no disease.

Exclusion Criteria:

• Patients with history of any medication treatment within 15 days before the beginning of the research, history of allergy to the drugs, substances or materials used in this study, pregnancy or lactation

+Locations (1)

FacilityCityCountryStatus
Universidade Federal dos Vales do Jequitinhonha e MucuriDiamantina, Minas GeraisBrazil